My guess is that NCM's royalties are around 10 to 20% of the revenue related to the sale of CBD oil used. PURA said they have a 75% profit margin so I don't think that it could be much higher than that. NCM is trying to get into the Prescription CBD market, they must have made this deal with USMJ/PURA to get some revenue to help fund R&D. NCM may have made a better deal than they planned if PURA can run up sales.
News 
Market Data 
Discover 
